首页> 外国专利> A process for the production of alpha-human atrial natriuretic polypeptide

A process for the production of alpha-human atrial natriuretic polypeptide

机译:生产α-人心房利钠多肽的方法

摘要

A process for the production of alpha -human atrial natriuretic polypeptide ( alpha -hANP) involves firstly culturing a microorganism which has been transformed with an expression vector comprising a synthetic gene encoding the amino acid sequence of a protective peptide-fused alpha -hANP in a culture medium. Subsequently recovering the protective peptide-fused alpha -hANP from the culture broth and then removing the protective peptide part from the peptide-fused polypeptide. In addition to the process itself, chemically synthesised genes for alpha -hANP and protective peptide-fused alpha -hANP are also described together with the corresponding recombinant vectors and transformants comprising the same. alpha -hANP is known to be useful as an antihypertensive diuretic agent.
机译:产生α-人心房利钠多肽(α-hANP)的方法包括首先培养已用表达载体转化的微生物,所述表达载体包含编码保护肽融合的α-hANP的氨基酸序列的合成基因。培养基。随后从培养液中回收与保护肽融合的α-hANP,然后从与肽融合的多肽中去除保护肽部分。除了该方法本身之外,还描述了α-hANP和保护性肽融合的α-hANP的化学合成基因,以及相应的重组载体和包含它们的转化体。已知α-hANP可用作抗高血压利尿剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号